ARTICLE | Clinical News
Myfortic mycophenolic acid regulatory update
May 26, 2008 7:00 AM UTC
FDA issued a Dear Healthcare Professional letter warning that post-marketing reports of spontaneous abortion and birth defects in infants of female patients receiving immunosuppressive agents CellCep...